The method for breast cancer grade prediction and pathway analysis based on improved multiple kernel learning

Breast cancer histologic grade represents the morphological assessment of the tumor's malignancy and aggressiveness, which is vital in clinically planning treatment and estimating prognosis for patients. Therefore, the prediction of breast cancer grade can markedly elevate the detection of early breast cancer and efficiently guide its treatment. With the advent of high-throughput profiling technology, a large number of data of different types are rapidly generated, and each data provides its unique biological insight. Although many researches focused on cancer grade prediction, hardly most of them attempted to integrate multiple data types, by which we cannot only improve and boost results obtained from learning method, but also have a good understanding or explanation of biological issues. In this paper, we take advantage of a sophisticated supervised learning method called multiple kernel learning (MKL) to design a breast cancer grading predictor fusing heterogeneous data for classification of breast cancer histopathology. Furthermore, we modify our model by involving biological pathway information. The new model can evaluate the significance of various pathways in which differential expression genes fall between different breast cancer grades. The merits of the novel model are lucubration in bridging between omics data and various phenotypes of breast cancer grades, and providing an auxiliary method integrating omics data of cancer mechanism research. In experiments, the proposed method outperforms other state-of-the-art methods and has abundant biological interpretation in explaining differences between breast cancer grades.

[1]  Rich Caruana,et al.  Ensemble selection from libraries of models , 2004, ICML.

[2]  Sandra A O'Toole,et al.  The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy , 2013, Breast Cancer Research.

[3]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[4]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[5]  G. Trinchieri,et al.  Molecular Pathways Molecular Pathways : Toll-like Receptors in the Tumor Microenvironment — Poor Prognosis or New Therapeutic Opportunity , 2013 .

[6]  Lei Wang,et al.  Sample-Adaptive Multiple Kernel Learning , 2014, AAAI.

[7]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[8]  H. Moses,et al.  Stromal fibroblasts in cancer initiation and progression , 2004, Nature.

[9]  XIALI ZHANG,et al.  Taurine induces the apoptosis of breast cancer cells by regulating apoptosis-related proteins of mitochondria. , 2015, International journal of molecular medicine.

[10]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[11]  Mehryar Mohri,et al.  L2 Regularization for Learning Kernels , 2009, UAI.

[12]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[13]  Sebastian Nowozin,et al.  On feature combination for multiclass object classification , 2009, 2009 IEEE 12th International Conference on Computer Vision.

[14]  Mehryar Mohri,et al.  Generalization Bounds for Learning Kernels , 2010, ICML.

[15]  Ethem Alpaydin,et al.  Multiple Kernel Learning Algorithms , 2011, J. Mach. Learn. Res..

[16]  Z. Werb,et al.  The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.

[17]  M. Kloft,et al.  l p -Norm Multiple Kernel Learning , 2011 .

[18]  S. V. N. Vishwanathan,et al.  Multiple Kernel Learning and the SMO Algorithm , 2010, NIPS.

[19]  Yasuhiro Katagiri,et al.  Role for chondroitin sulfate glycosaminoglycan in NEDD9-mediated breast cancer cell growth. , 2015, Experimental cell research.

[20]  M. Nitti,et al.  Role of Glutathione in Cancer Progression and Chemoresistance , 2013, Oxidative medicine and cellular longevity.

[21]  Sham S. Kakar,et al.  Identification of Metabolites in the Normal Ovary and Their Transformation in Primary and Metastatic Ovarian Cancer , 2011, PloS one.

[22]  Alexander Zien,et al.  lp-Norm Multiple Kernel Learning , 2011, J. Mach. Learn. Res..

[23]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[24]  O Sukocheva,et al.  Role of sphingolipids in oestrogen signalling in breast cancer cells: an update. , 2014, The Journal of endocrinology.

[25]  F. Davis,et al.  Calcium Channels and Pumps in Cancer: Changes and Consequences* , 2012, The Journal of Biological Chemistry.

[26]  Mitsuo Katano,et al.  Hedgehog signaling pathway as a therapeutic target in various types of cancer , 2011, Cancer science.

[27]  Peter H Watson,et al.  Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  Hiroyuki Tomita,et al.  Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. , 2011, Cancer cell.

[29]  Guoqing Wang,et al.  Gene-Expression Signatures Can Distinguish Gastric Cancer Grades and Stages , 2011, PloS one.

[30]  Yoshiki Tsuchiya,et al.  Regulatory mechanisms and functions of MAP kinase signaling pathways , 2006, IUBMB life.

[31]  Dragana Nikitovic,et al.  Glycosaminoglycans: key players in cancer cell biology and treatment , 2012, The FEBS journal.

[32]  B. Lippitz,et al.  Cytokine patterns in patients with cancer: a systematic review. , 2013, The Lancet. Oncology.

[33]  M. Ritchie,et al.  Methods of integrating data to uncover genotype–phenotype interactions , 2015, Nature Reviews Genetics.

[34]  Shu Ichihara,et al.  Breast cancer prognostic classification in the molecular era: the role of histological grade , 2010, Breast Cancer Research.

[35]  L C Murphy,et al.  Lumican and decorin are differentially expressed in human breast carcinoma , 2000, The Journal of pathology.

[36]  Mehryar Mohri,et al.  Learning Non-Linear Combinations of Kernels , 2009, NIPS.

[37]  Mårten Fernö,et al.  Grading Breast Cancer Tissues Using Molecular Portraits* , 2013, Molecular & Cellular Proteomics.

[38]  H. Llewelyn Roderick,et al.  Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival , 2008, Nature Reviews Cancer.

[39]  C. Dinarello Historical insights into cytokines , 2007, European journal of immunology.

[40]  S. V. N. Vishwanathan,et al.  SPF-GMKL: generalized multiple kernel learning with a million kernels , 2012, KDD.

[41]  K. Wong,et al.  Recent developments in anti-cancer agents targeting the Ras/Raf/ MEK/ERK pathway. , 2009, Recent patents on anti-cancer drug discovery.

[42]  W. Du,et al.  Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging , 2015, PloS one.

[43]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[44]  Kazuaki Takabe,et al.  The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis. , 2012, Lymphatic research and biology.

[45]  Sarah Spiegel,et al.  Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling. , 2008, Journal of lipid research.

[46]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[47]  Kenji Ishimoto,et al.  The Role of PPARs in Cancer , 2008, PPAR research.

[48]  J. Morales-Montor,et al.  The Role of Chemokines in Breast Cancer Pathology and Its Possible Use as Therapeutic Targets , 2014, Journal of immunology research.

[49]  S. Rocchi,et al.  PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials , 2012, PPAR research.

[50]  D. A. Gomes,et al.  Stem cells and calcium signaling. , 2012, Advances in experimental medicine and biology.

[51]  Kees Jalink,et al.  Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent , 2013, Oncogene.

[52]  Manik Varma,et al.  More generality in efficient multiple kernel learning , 2009, ICML '09.

[53]  Anant Madabhushi,et al.  Automated gland and nuclei segmentation for grading of prostate and breast cancer histopathology , 2008, 2008 5th IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[54]  N. Prevarskaya,et al.  Calcium in tumour metastasis: new roles for known actors , 2011, Nature Reviews Cancer.

[55]  M. Scott,et al.  Communicating with Hedgehogs , 2005, Nature Reviews Molecular Cell Biology.

[56]  Huan Liu,et al.  Feature selection for classification: A review , 2014 .

[57]  Sha Cao,et al.  Cancer may be a pathway to cell survival under persistent hypoxia and elevated ROS: A model for solid‐cancer initiation and early development , 2015, International journal of cancer.

[58]  M. Scott,et al.  Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer. , 2010, Trends in molecular medicine.